Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-253929

Options or other derivatives

  • General Counsel and Secretary acquired 17,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

KASINGER JAMES R. · General Counsel and Secretary

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-29 Grant or award : show line 1 in the form Restricted Stock Units +17,000 17,000 D
Loading xslF345X06/ownership.xml…